Navigating the future of gastric cancer treatment: a review on the impact of antibody-drug conjugates
Abstract Gastric cancer, marked by its high incidence and poor prognosis, demands the urgent development of novel and effective treatment strategies, especially for patients ineligible for surgery or those who have had limited success with chemotherapy, radiotherapy and targeted therapies. Recently,...
Saved in:
| Main Authors: | Qingling Yin, Yanlong Zhang, Xueqing Xie, Meijun Hou, Xunsheng Chen, Jie Ding |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Cell Death Discovery |
| Online Access: | https://doi.org/10.1038/s41420-025-02429-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
by: Ruili Wang, et al.
Published: (2025-04-01) -
Antibody drug conjugates
by: Stalin Bala, et al.
Published: (2020-01-01) -
Antibody-drug conjugates in cancer therapy: applications and future advances
by: Rou Long, et al.
Published: (2025-05-01) -
Antibody drug conjugates in the clinic
by: Edidiong Udofa, et al.
Published: (2024-11-01) -
Antibody-Drug Conjugates in Cancer
by: Marcus Vetter
Published: (2024-06-01)